Adani Enterp.

2534.2 29.80

Adani Ports

1471.7 15.00

Apollo Hospitals

6942.5 66.50

Asian Paints

2245.2 1.70

Axis Bank

1194.6 35.60

Bajaj Auto

8637 79.50

Bajaj Finance

9371.5 437.50

Bajaj Finserv

1990 46.00

Bharat Electron

390.7 -2.80

Bharti Airtel

1870.2 -8.60

Cipla

1504.2 14.40

Coal India

398.95 4.05

Dr Reddy's Labs

1320.9 30.30

Eicher Motors

5394 85.50

Eternal Ltd

261.86 5.30

Grasim Inds

2574.4 20.00

HCL Technologies

1637.7 5.30

HDFC Bank

1978.7 29.10

HDFC Life Insur.

755.1 -6.50

Hero Motocorp

4268 89.10

Hind. Unilever

2389.8 13.40

Hindalco Inds.

650.15 12.90

ICICI Bank

1459.7 4.90

IndusInd Bank

822.85 19.65

Infosys

1563.8 9.50

ITC

421.05 1.95

JSW Steel

1004.9 36.15

Kotak Mah. Bank

2073.4 33.50

Larsen & Toubro

3656.3 13.70

M & M

3106.5 64.90

Maruti Suzuki

12462 336.00

Nestle India

2417.2 15.90

NTPC

332.85 4.20

O N G C

240.06 2.29

Power Grid Corpn

295.8 1.55

Reliance Industr

1443.5 1.10

SBI Life Insuran

1780.6 5.80

Shriram Finance

688.25 36.80

St Bk of India

813.05 7.05

Sun Pharma.Inds.

1679.2 -3.90

Tata Consumer

1115.6 3.70

Tata Motors

711 0.85

Tata Steel

157.49 -0.48

TCS

3384.2 13.10

Tech Mahindra

1571.1 8.30

Titan Company

3559.9 55.90

Trent

5777 104.00

UltraTech Cem.

11253 94.00

Wipro

248.59 0.65

IPO-Synopsis
Alivus Life Sciences Ltd
Initial public offer of 21,022,222 equity shares of face value of Rs. 2 each ("equity shares") of Glenmark Life Sciences Limited ("Company" or "Issuer") for cash at a price of Rs. 720 per equity share (including a share premium of Rs. 718 per equity share) aggregating to Rs. 1513.60 crores (the "offer") comprising a fresh issue of 14,722,222 equity shares aggregating to Rs. 1060 crores (the "fresh issue") and an offer for sale of up to 6,300,000 equity shares by Glenmark Pharmaceuticals Limited ("Promoter Selling Shareholder") and such equity shares, The "offered shares") aggregating to Rs. 453.60 crores (The "offer for sale"). The offer shall constitute 17.16% of the post-offer paid-up equity share capital of the company. The face value of equity shares is Rs. 2 each. Offer Price : Rs. 720 per Equity Share of face value of Rs. 2 each. Anchor Investor offer price: Rs. 720 per Equity share. The Offer Price is 360 times the face value.
Issue
Opens On Closes On
27-Jul-21 29-Jul-21
Money Payable On
Application Allotment
720.00 0.00
Minimum Application for shares in Nos : 20 Further Multiples of : 20
Cr Lead Managers to the Issue
Project Cost (.Cr) 1060.00 BOB Capital Markets Ltd
Project Financed through Current Offer (.Cr) 1513.60  
Post Issue Equity Share Capital (.Cr) 24.51
Issue Price () 720.00
Projects
Payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company pursuant to the Business Purchase agreement
Funding capital expenditure requirements
General corporate purposes
Promoted By
Glenmark Pharmaceuticals Ltd
Listing At
BSE
NSE
Registrar to the Issue
No Data Available

DJIA 42779.54
438.80 1.04%
S&P 500 6020.48
60.18 1.01%
HANG SENG 23792.55
-114.43 -0.48%
NIKKEI 225 37687.53
133.04 0.35%
FTSE 100 8837.91
26.87 0.30%
NIFTY 25003.05
252.15 1.02%
×
Ask Your Question
close
refresh